Evaluation of the efficiency of chemical cartridges for respiratory protection against SARS-CoV-2

被引:1
|
作者
Paiva, Jose D. [1 ]
Neto, Paulo C. [1 ]
机构
[1] Inst Fed Pernambuco, Dept Res & Extens, BR-50750320 Abreu E Lima, PE, Brazil
来源
COGENT ENGINEERING | 2022年 / 9卷 / 01期
关键词
COVID-19; respirators; risk control; PPE; aerodispersoids;
D O I
10.1080/23311916.2022.2049484
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The shortage of PFF2, N95, KN95, and FFP2 respirators in the COVID-19 pandemic required that alternative respiratory protection measures be adopted to reduce the number of cases of the disease. Given this scenario, with the purpose of proving that chemical cartridges offer some degree of protection against aerodispersoids, among these those of biological origin, such as SARS-CoV-2, the filtering efficiency of chemical cartridges was evaluated. The evaluation of the filtering efficiency of cartridges was performed using the air filter test method, which uses micrometric air particles for the penetration test. The research proved that chemical cartridges, in general, have an average efficiency above 85% for respiratory protection against aerodispersoids. The multigas cartridge and organic vapor/acid gas cartridge had an average filtration efficiency of 91%. Chemical cartridges associated with facial or semi-facial respirators can become powerful resources for respiratory protection for people exposed to the virus, when the use of PFF2 or equivalent respirators is not possible.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Evaluation of the EasyNAT SARS-CoV-2 assay PCR test for the diagnosis of SARS-CoV-2 infection
    Fernandez-Sanchez, Fernando
    Martin-Bautista, Elena
    Rivas-Ruiz, Francisco
    Wu, Winnie
    Garcia-Aranda, Marilina
    JOURNAL OF VIROLOGICAL METHODS, 2024, 326
  • [42] A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2
    Kivrak, Arif
    Ulas, Berdan
    Kivrak, Hilal
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
  • [43] Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
    Chao, Chiao-Hsuan
    Cheng, Dayna
    Huang, Sheng-Wen
    Chuang, Yung-Chun
    Yeh, Trai-Ming
    Wang, Jen-Ren
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] Evaluation of SARS-CoV-2 with a biophysical perspective
    Barlas, Sait Berk
    Adalier, Nur
    Dasdag, Omer
    Dasdag, Suleyman
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2021, 35 (01) : 392 - 406
  • [45] Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants
    Noor, Rashed
    VIRUSES-BASEL, 2022, 14 (11):
  • [46] A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Istuti Saraswat
    Sarmistha Saha
    Anuja Mishra
    Toxicology and Environmental Health Sciences, 2023, 15 : 315 - 324
  • [47] Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Zhang, Chao
    Zhou, Chenliang
    Shi, Li
    Liu, Ge
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (10) : 2366 - 2369
  • [48] A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    Saraswat, Istuti
    Saha, Sarmistha
    Mishra, Anuja
    TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES, 2023, 15 (04) : 315 - 324
  • [49] Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
    Aherfi, Sarah
    Pradines, Bruno
    Devaux, Christian
    Honore, Stephane
    Colson, Philippe
    La Scola, Bernard
    Raoult, Didier
    FUTURE MICROBIOLOGY, 2021, 16 (17) : 1341 - 1370
  • [50] Current state of vaccination against SARS-CoV-2
    Iking-Konert, Christof
    Specker, Christof
    Krueger, Klaus
    Schulze-Koops, Hendrik
    Aries, Peer
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (02): : 158 - 164